Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
28.33
+1.36 (5.04%)
Sep 17, 2025, 2:45 PM CST
Chengdu Olymvax Biopharmaceuticals Employees
Chengdu Olymvax Biopharmaceuticals had 470 employees as of December 31, 2024. The number of employees decreased by 1 or -0.21% compared to the previous year.
Employees
470
Change (1Y)
-1
Growth (1Y)
-0.21%
Revenue / Employee
1.44M CNY
Profits / Employee
133.70K CNY
Market Cap
11.40B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 470 | -1 | -0.21% |
Dec 31, 2023 | 471 | 31 | 7.05% |
Dec 31, 2022 | 440 | 31 | 7.58% |
Dec 31, 2021 | 409 | 69 | 20.29% |
Dec 31, 2020 | 340 | 115 | 51.11% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Jiangsu Hengrui Medicine | 20,238 |
WuXi AppTec | 39,414 |
Shenzhen Mindray Bio-Medical Electronics | 21,667 |
Sichuan Biokin Pharmaceutical | 2,521 |
Shanghai United Imaging Healthcare | 8,173 |
Zhangzhou Pientzehuang Pharmaceutical., | 2,839 |
Aier Eye Hospital Group | 42,693 |
Yunnan Baiyao Group Co.,Ltd | 9,277 |